1. Biotechnology

New patent expiration for Ferrer Internacional drug XEPI – DrugPatentWatch

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for XEPI
Annual Drug Patent Expirations for XEPI

Xepi is a drug marketed by Ferrer Internacional and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has forty-four patent family members in twenty-five countries.

The generic ingredient in XEPI is ozenoxacin. One supplier is listed for this compound. Additional details are available on the ozenoxacin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Comments to: New patent expiration for Ferrer Internacional drug XEPI – DrugPatentWatch

Login

Welcome to Life Science News!

"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.